Urges US Department of Veterans Affairs to study use of hyperbaric oxygen therapy for veterans.
Impact
The resolution highlights previous legislative efforts by the Department of Veterans Affairs (VA) to incorporate HBOT as a treatment option for veterans with treatment-resistant PTSD. This suggests a recognition of the need for alternative therapies to address conditions that do not respond well to conventional treatments. The resolution further emphasizes that extensive studies should be carried out to determine the effectiveness of HBOT in improving the well-being of veterans who have served the nation.
Summary
AJR178 is a joint resolution introduced in the New Jersey State Legislature urging the United States Department of Veterans Affairs to conduct a study on the efficacy of hyperbaric oxygen therapy (HBOT) as a treatment for veterans suffering from post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). This resolution recognizes the significant mental health challenges faced by veterans, with 23% suffering from PTSD at some point in their lives due to exposure to traumatic events during service, including combat and military accidents.
Contention
While AJR178 advocates for the study of HBOT, it brings attention to the ongoing debate regarding the best treatment modalities for PTSD among veterans. Critics may argue about the efficacy and safety of HBOT compared to established therapies, as well as the potential costs and resources involved in administering such treatments. The resolution therefore serves as a call for further investigation into experimental therapies as a viable option for veterans who have not benefitted from existing methods.
A resolution to urge the United States Food and Drug Administration to facilitate FDA regulated research on hyperbaric oxygen therapy for the treatment of Traumatic Brain Injury and Post Traumatic Stress Disorder.